Conversations with leading voices across yachting will continue across YachtWorld channels following successful Monaco debut

MIAMI, Oct. 6, 2026 /PRNewswire/ -- Following the successful debut of YachtWorld House at Monaco Yacht Show 2026, YachtWorld is bringing the conversations that took place inside the House to a wider global audience — sharing perspectives from some of yachting's most respected leaders across its social channels.

Over three days in Monaco, YachtWorld House brought together leaders from across shipbuilding, brokerage, yacht management, charter, technology, media, design and academia to discuss the changes shaping yachting today and what they mean for the industry moving forward.

The conversations went well beyond the Monaco Yacht Show itself. From the changing expectations of yacht buyers and the next generation of clients to AI, digital transformation, brokerage and data, yacht management, shipbuilding, media and future talent, the discussions addressed issues affecting businesses and professionals across the global yachting ecosystem.

Now, YachtWorld will share highlights from those conversations across its social channels, giving the wider industry access to perspectives and insights exchanged inside the House.

"Bringing this group together in one place gave us the opportunity to hear different perspectives on many of the same changes we are seeing across the industry," said Courtney Chalmers, Chief Brand & Communications Officer at YachtWorld. "These weren't conversations that were only relevant in Monaco. They are conversations the industry is having globally, and we want to continue them by sharing these perspectives with the broader YachtWorld community."

The YachtWorld House Conversation Series brought together voices including award-winning yacht designer, Giorgio Cassetta; Filippo Buonpensiero of Cantieri delle Marche; Toby Moore, CEO of Monaco Yacht Show; Paris Bellamis of Oceanco; Steve Bailet of IYC; Alex von Stein of SOS Yachting; Camilla Calza of Benetti; and media guests including Bill Springer, Yachting Editor at Forbes.

Hosted by Annalisa Tarquini and Filippo Ceragioli of the International University of Monaco (IUM), the conversations were organized around three themes — Next Generation, Ecosystem and Human Experience — providing a range of perspectives on where yachting is today and how it continues to evolve.

The breadth of voices gathered at YachtWorld House reflects YachtWorld's longstanding position within the global yachting community. For more than 30 years, YachtWorld has connected yacht buyers, sellers and industry professionals around the world. YachtWorld House builds on that role by creating a new forum for the people shaping the industry to exchange ideas, challenge assumptions and share their expertise with a wider audience.

The conversations were one part of a broader YachtWorld House experience created and curated by The Style Lab in collaboration with YachtWorld. The setting brought together industry dialogue with hospitality, design and gastronomy, creating an environment where scheduled interviews continued into informal conversations and new connections throughout the three days.

Papillon Milano 1990 brought its distinctive approach to Italian and Mediterranean hospitality to the House, while Unopiù shaped the outdoor environment overlooking Port Hercule. IUM added an academic and next-generation perspective, with students participating throughout the event alongside senior industry figures.

Following the response to its Monaco debut, YachtWorld is exploring opportunities to bring YachtWorld House to other key moments in the global yachting calendar, while continuing to use its platforms to extend the ideas and perspectives that emerge from the House to the industry more broadly.

About YachtWorld

YachtWorld is the largest online marketplace for buying and selling yachts, connecting millions of buyers with a global network of brokers, dealers, and private sellers. With AI-driven search tools, real-time market insights, and comprehensive financing options, YachtWorld makes yacht discovery and ownership more accessible, seamless, and enjoyable.

Media Contact:

Courtney Chalmers

Chief Brand & Communications Officer

press@boats.com 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/yachtworld-house-brings-industry-perspectives-beyond-monaco-302899951.html

Roche versucht nach einer Phase von Forschungsrückschlägen und Belastungen durch auslaufende Patente, das Tempo in der Medikamentenentwicklung deutlich zu erhöhen. Am Pharma-Investorentag unterstrich die Pharmasparte des Basler Konzerns den Anspruch, in Forschung und Entwicklung weiter zur Spitzengruppe zu gehören. Zentral sind dabei ein strengeres Management der Pipeline, Effizienzprogramme und der verstärkte Einsatz künstlicher Intelligenz entlang der Wertschöpfungskette.

Pharma-Chefin Teresa Graham verwies auf eine sichtbar verbesserte Bilanz seit dem letzten „Pharma Day“: In zehn zulassungsrelevanten Studien habe Roche die gesetzten Ziele erreicht, sechs Programme seien in die zulassungsrelevende Phase vorgerückt, drei weitere in Phase II. Insgesamt verfügt Roche nach eigenen Angaben über bis zu 20 neue Wirkstoffe, die bis 2030 auf den Markt kommen könnten. Einzelne Kandidaten wie das Brustkrebsmittel Giredestrant traut der Konzern dabei jeweils Spitzenumsätze im zweistelligen Milliardenbereich zu.

Um diese Ambitionen abzusichern, verschärft Roche die internen Selektionskriterien. Ende 2023 führte der Konzern mit „The Bar“ einen neuen Bewertungsrahmen für die Pipeline ein. Nur Wirkstoffkandidaten, die klar definierte Anforderungen erfüllen, werden weiterentwickelt. Medizinchef Levi Garraway bezeichnete „The Bar“ als Leitbild für Forschung und Entwicklung. Die Auswahl potenzieller Projekte sei damit spürbar strenger geworden – mit dem Ziel, Ressourcen konsequent auf die Erfolg versprechendsten Programme zu konzentrieren und die Erfolgsquote in späten Studienphasen zu stabilisieren oder weiter zu erhöhen.

Parallel dazu treibt Roche ein Effizienzprogramm voran, um Mittel aus weniger renditestarken in wachstumsstärkere Projekte umzuschichten. Die Entwicklung neuer Medikamente soll deutlich beschleunigt werden, was insbesondere in umkämpften Indikationen wie Onkologie sowie in wachstumsstarken Bereichen wie Herz-Kreislauf- und Stoffwechselerkrankungen an Bedeutung gewinnt. Damit will Roche erwartete Umsatzeinbussen durch Patentabläufe mehr als kompensieren und sich bis zum Ende des Jahrzehnts ein Portfolio aufbauen, das von mehreren potenziellen Blockbustern getragen wird.